臨床泌尿器科78巻6号

2024年05月発行

特集 泌尿器科医のための核医学―正しく理解して潮流に乗れ!

〈従来の核医学〉

泌尿器科領域におけるFDG-PET/CT

著者： 渡邊史郎¹

所属機関： ¹北海道大学病院 核医学診療科

ページ範囲：P.362 - P.369

文献概要

▶ポイント

・泌尿器系の悪性腫瘍ではFDG集積が低いときも多く，原発巣評価の有用性は限定的である．

・転移性病変，再発評価や進行性・予後の評価にFDG-PETが有用であり，患者管理に影響を与える．

・特に進行期や転移を有する症例，病理学的な異型度が高い症例ではFDG-PETを積極的に利用することが推奨される．

参考文献

1） Wang HY, et al : Meta-analysis of the diagnostic performance of ［18F］ FDG-PET and PET/CT in renal cell carcinoma. Cancer Imaging 12 : 464-474, 2012

2） Ma H, et al : Diagnostic performance of 18F-FDG PET or PET/CT in restaging renal cell carcinoma : a systematic review and meta-analysis. Nucl Med Commun 38 : 156-163, 2017

3） Alongi P, et al : Recurrent renal cell carcinoma : clinical and prognostic value of FDG PET/CT. Eur J Nucl Med Mol Imaging 43 : 464-473, 2016

4） Posada Calderon L, et al : Advances in Imaging-Based Biomarkers in Renal Cell Carcinoma : A Critical Analysis of the Current Literature. Cancers （Basel） 15 : 354, 2023

F-FDG PET/CT and Urothelial Carcinoma : Impact on Management and Prognosis-A Multicenter Retrospective Study. Cancers （Basel） 11 : 700, 2019

6） Asai S, et al : Fluorodeoxyglucose positron emission tomography/computed tomography for diagnosis of upper urinary tract urothelial carcinoma. Int J Clin Oncol 20 : 1042-1047, 2015

F-fluorodeoxyglucose Positron Emission Tomography with Computed Tomography for Lymph Node Staging in Patients with Upper Tract Urothelial Carcinoma. Eur Urol Oncol 3 : 73-79, 2020

F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Upper Tract Urothelial Carcinoma : Impact on Detection of Metastases and Patient Management. Urol Int 96 : 65-72, 2016

9） Girard A, et al : The Role of 18F-FDG PET/CT in Guiding Precision Medicine for Invasive Bladder Carcinoma. Front Oncol 10 : 565086, 2020

10） Inamura K, et al : Abnormal 18F-FDG uptakes in the prostate due to two different conditions of urine reflux : a mimicker of prostate cancer. Springerplus 5 : 46, 2016

F-fluorodeoxyglucose positron emission tomography/computed tomography （PET/CT） is accurate for high-grade prostate cancer bone staging when compared to bone scintigraphy. Can Urol Assoc J 15 : 301-307, 2021

F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Localised Gleason 8-10 Prostate Cancers Identifies Very High-risk Patients for Early Recurrence and Resistance to Castration. Eur Urol Focus 5 : 998-1006, 2019